Browsing by Author "Alatawi, Fahad O"
Now showing items 1-1 of 1
-
BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells.
Alhoshani, Ali; Alatawi, Fahad O; Al-Anazi, Fawaz E; Attafi, Ibraheem M; Zeidan, Asad; Agouni, Abdelali; El Gamal, Heba M; Shamoon, Licia S; Khalaf, Sarah; Korashy, Hesham M... more authors ... less authors ( Dove Medical Press , 2020 , Article)Venetoclax (VCX) is a selective BCL-2 inhibitor approved for the treatment of leukemia and lymphoma. However, the mechanisms of anti-cancer effect of VCX either as a monotherapy or in combination with other chemotherapeutic ...